UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001569
Receipt number R000001772
Scientific Title A multicenter study on warfarin use and optimal anticoagulation levels for prevention of cardiogenic embolism in Japanese patients with atrial fibrillation: J-RHYTHM Registry
Date of disclosure of the study information 2009/01/05
Last modified on 2013/09/10 11:35:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter study on warfarin use and optimal anticoagulation levels for prevention of cardiogenic embolism in Japanese patients with atrial fibrillation: J-RHYTHM Registry

Acronym

J-RHYTHM Registry

Scientific Title

A multicenter study on warfarin use and optimal anticoagulation levels for prevention of cardiogenic embolism in Japanese patients with atrial fibrillation: J-RHYTHM Registry

Scientific Title:Acronym

J-RHYTHM Registry

Region

Japan


Condition

Condition

atrial fibrillation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the present status of warfarin use and establish adequate intensity of PT-INR in Japanese patients with atrial fibrillation.

Basic objectives2

Others

Basic objectives -Others

Registration and follow-up

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Investigation of clinical background at the development of following clinical event; symptomatic cerebral infarction, systemic embolism, major bleeding, all cause of death Optimal PT-INR for Japanese patients with atrial fibrillation

Key secondary outcomes

Preventive effects of various medications including warfarin, antithrombotics drugs and others for the treatment of Japanese patients with atrial fibrillation


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

all patient with atrial fibrillation accepted the informal consent

Key exclusion criteria

inadequate patients judged by their physician

Target sample size

6000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Inoue

Organization

University of Toyama

Division name

Second Department of Internal Medicine

Zip code


Address

2630 Sugitani Toyama-shi, Toyama

TEL

076-434-2281

Email

hiroshi@med.u-toyama.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hirotsugu Atarashi

Organization

Nippon Medical School Tama-Nagayama Hospital

Division name

Internal Medicine

Zip code


Address

1-7-1 Nagayama Tama-shi, Tokyo

TEL

042-371-2111

Homepage URL


Email

jr-registry@nms.ac.jp


Sponsor or person

Institute

The Japanese Society of Electrocardiology

Institute

Department

Personal name



Funding Source

Organization

Japan Heart Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 01 Month 05 Day


Related information

URL releasing protocol

http://www.sciencedirect.com/science/article/pii/S0914508710001784

Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 10 Month 09 Day

Date of IRB


Anticipated trial start date

2009 Year 01 Month 01 Day

Last follow-up date

2011 Year 07 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prevalence of warfarin use in Japanese AF patients, evaluation of recommended PT-INR in Japanese AF patient


Management information

Registered date

2008 Year 12 Month 12 Day

Last modified on

2013 Year 09 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001772


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name